BGM Group

Produces oxytetracycline API, crude heparin sodium and licorice preparations through its biopharmaceutical division, alongside diversified pharmaceutical and allied products. AI solutions and insurance business are additional reported activities, serving insurance companies, brokers and consumers through sales, underwriting, claims and customer-service workflows.

Operates in China through subsidiaries and a consolidated VIE under a Cayman Islands holding company. Du Xiao Bao and Bao Wang use data mining and AI-agent technology for insurance-oriented solutions, while the company also focuses on intelligent robots, algorithmic computing power, cloud computing and biopharmaceuticals. Its structure depends on contractual VIE arrangements whose enforceability and regulatory treatment under PRC law remain uncertain.